PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.17%
Net income growth under 50% of AVGO's 18.69%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
9.17%
Some D&A expansion while AVGO is negative at -3.72%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
78.57%
Deferred tax of 78.57% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-20.00%
Both cut yoy SBC, with AVGO at -3.37%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
126.17%
Slight usage while AVGO is negative at -18.33%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
137.97%
AR growth well above AVGO's 169.96%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-47.48%
Both reduce yoy inventory, with AVGO at -15.65%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
121.05%
A yoy AP increase while AVGO is negative at -1035.48%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
227.40%
Some yoy usage while AVGO is negative at -128.90%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
83.24%
Some yoy increase while AVGO is negative at -75.72%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
56.45%
Operating cash flow growth above 1.5x AVGO's 4.27%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-32.33%
Both yoy lines negative, with AVGO at -36.47%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Negative yoy acquisition while AVGO stands at 97.78%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-76.59%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-27.79%
We reduce yoy sales while AVGO is 4.71%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-112.20%
We reduce yoy other investing while AVGO is 2133.33%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-272.49%
We reduce yoy invests while AVGO stands at 125.81%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-39.00%
We cut debt repayment yoy while AVGO is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
39.29%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
15.74%
Buyback growth below 50% of AVGO's 45.53%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.